IXHL Stock Analysis: Buy, Sell, or Hold?
IXHL - Incannex Healthcare Limited American Depositary Shares
$0.28
0.00 (-0.43%)
▼
5d:
-10.63%
30d:
-29.31%
90d:
-20.9%
WAIT
LOW Confidence
Analysis Updated: Feb 4, 2026 12:00 AM ET
Earnings: Feb 13, 2026
8d
Get Alerted When IXHL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called IXHL this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: IXHL is down 10.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: IXHL is down 10.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: IXHL is currently trading at $0.28, which is considered oversold relative to its 30-day fair value range of $0.32 to $0.39. From a valuation perspective, the stock is trading at a discount (Forward PE: 4.5) compared to its historical average (5.7). Remarkably, the market is currently pricing in an annual earnings decline of 7.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, IXHL is in a downtrend. Immediate support is located at $0.26, while resistance sits at $0.37.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IXHL is in a downtrend. Immediate support is located at $0.26, while resistance sits at $0.37.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.32 -
$0.39
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- WARNING: Recommendation downgraded due to -10.6% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.32 -
$0.39
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.26
Resistance Level
$0.37
Current Trend
Downtrend
Technical data as of
Feb 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.54
Revenue Growth (YoY)
-100.0%
Valuation Discount vs History
-7.5% cheaper
PE vs Historical
4.5 vs 5.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.5%
(market-implied from PE analysis)
1-Year Target
$0.26
(-8%)
2-Year Target
$0.24
(-14%)
3-Year Target
$0.22
(-21%)
3-Yr Target (if PE normalizes)
(PE: 5→6)
$0.28
(-1%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 4.5 to 5.7
Stabilization Target:
$0.35
(+25.7%)
PE Expansion Potential:
+25.7%
Last updated: February 04, 2026 2:27 PM ET
Data refreshes hourly during market hours. Next update: 3:27 PM
Data refreshes hourly during market hours. Next update: 3:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IXHL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$180 | 58 HOLD |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$154 | 68 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$83 | 55 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 58 HOLD |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
11 analysts |
$37 | 59 HOLD |
